SCHEMBL30434560

SCHEMBL30434560

COc1cc2nc(-c3cc(C)c(O)c(C)c3)[nH]c(=O)c2cc1OC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GUSB P08236 3/20 0.50
▸ CYP1A1 P04798 2/20 0.50
▸ CYP1B1 Q16678 2/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ PDE3B Q13370 1/20 0.49
▸ PDE3A Q14432 1/20 0.49
▸ KDM4E B2RXH2 2/20 0.47
▸ GAA P10253 1/20 0.47
▸ MEN1 O00255 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ POLB P06746 2/20 0.46
▸ TSHR P16473 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ AMY1A P0DUB6 1/20 0.45
▸ TUBB4A P04350 1/20 0.45
▸ TUBB P07437 1/20 0.45
▸ TUBA3C P0DPH7 1/20 0.45
▸ TUBA1B P68363 1/20 0.45
▸ TUBA4A P68366 1/20 0.45
▸ TUBB4B P68371 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL146515 1.00 GUSB (0.50) GUSBCYP1A1CYP1B1CYP1A2PDE3B
SCHEMBL144139 0.83 BRD4 (0.56) GUSBCYP1A1CYP1B1CYP1A2PDE3B
SCHEMBL30055885 0.83 BRD4 (0.56) GUSBCYP1A1CYP1B1CYP1A2PDE3B
SCHEMBL19582552 0.82 GUSB (0.54) GUSBCYP1A1CYP1B1CYP1A2KDM4E
SCHEMBL348447 0.81 BRD4 (0.49) GUSBCYP1A1CYP1B1CYP1A2PDE3B
SCHEMBL259473 0.80 GUSB (0.67) GUSBCYP1A1CYP1B1CYP1A2KDM4E
SCHEMBL147943 0.79 BRD4 (0.69) BRD4
SCHEMBL30054393 0.79 BRD4 (0.69) BRD4
SCHEMBL20771302 0.78 HPGD (0.57) GUSBCYP1A1CYP1B1CYP1A2PDE3B
SCHEMBL8499675 0.78 TNKS (0.67) GUSBCYP1A1CYP1B1CYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107252429-B Novel anti-inflammatory agent 雷斯韦洛吉克斯公司 2023-06-16 — — CN claimed
CN-107252429-B Novel anti-inflammatory agent 雷斯韦洛吉克斯公司 2023-06-16 — — CN disclosed
Send feedback